(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid structure 
             | 
        Common Name | (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid | ||
|---|---|---|---|---|
| CAS Number | 68538-85-2 | Molecular Weight | 473.43900 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H23N7O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
            Use of (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acidLevoleucovorin (Levofolinic acid) is the pharmacologically active levoisomer of racemic leucovorin. Levoleucovorin can be used as a rescue agent after high-dose Methotrexate (HY-14519) therapy, and in combination with fluorouracil for the research of advanced metastatic colorectal cancer[1].  | 
    
| Name | (6S)-5-formyltetrahydrofolic acid | 
|---|
| Description | Levoleucovorin (Levofolinic acid) is the pharmacologically active levoisomer of racemic leucovorin. Levoleucovorin can be used as a rescue agent after high-dose Methotrexate (HY-14519) therapy, and in combination with fluorouracil for the research of advanced metastatic colorectal cancer[1]. | 
|---|---|
| Related Catalog | |
| Target | 
                                    
                                     Human Endogenous Metabolite  | 
                            
| References | 
| Molecular Formula | C20H23N7O7 | 
|---|---|
| Molecular Weight | 473.43900 | 
| Exact Mass | 473.16600 | 
| PSA | 219.84000 | 
| LogP | 1.15290 |